Home > Healthcare > Pharmaceuticals > Active Pharmaceutical Ingredients > Cannabinoids Market

Cannabinoids Market Trends

Report ID: GMI5320
Published Date: Sep 2022
Report Format: PDF

Download Free Sample

Cannabinoids Market Trends

The growing use of cannabinoids, including CBD-based products for medical ailments will accelerate the industry expansion. Several pharmaceutical firms are deploying cannabis to alleviate pain and diseases such as asthma. Primarily triggered by the implementation of the Farm Bill in the U.S., there has been an exponential growth in the cannabinoids market given the product’s ability to manage anxiety, seizures, muscle disorders, and Parkinson’s disease, among others.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

In 2021, the global market for cannabinoids registered a valuation of over USD 11 billion and will expand at a CAGR of more than 20% during the forecast period of 2022-2030.

The cannabidiol (CBD) product segment was valued at over USD 9 billion in 2021 and is expected to show a considerable growth rate over the forecast period.

Europe cannabinoids market is anticipated to be worth over USD 17 billion by 2030, driven by the growing health consciousness and increasing presence of market players in the region.

The competitive landscape of the market includes companies such as Bedrocan, NuLeaf Naturals, LLC, Green Roads, Global Cannabinoids, Maricann Inc., Mile High Labs International Inc., Rhizo Sciences, Spark-CBD, and Folium Biosciences.